Tarsus Pharmaceuticals had a revenue of 118.70M in the quarter ending Sep 30, 2025, with 15.62%. This bring the company's revenue in the last twelve months to 366.10M, Decreased 23.88%. In the fiscal year ending Dec 31, 2024, Tarsus Pharmaceuticals had annual revenue of 182.95M with 948.62% growth.